Recombinant alpha-tumor necrosis factor-thymosin-alpha-1 (PHARMACLON)

N/A

Report date: 2022/03/23 17:09:28

Base Information

Drug NameRecombinant alpha-tumor necrosis factor-thymosin-alpha-1 (PHARMACLON)
Drug Alias NameTNF-T proteinRefnot
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor receptor agonists
TargetsTumor necrosis factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsNeoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2009/03/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPharmaclon
China Registration ClassN/A

Develop Information

Active CompaniesPharmaclon
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01XX
Related LinksN/A